midazolam has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, YL | 1 |
| Lin, JP | 1 |
| Liu, FE | 1 |
| Wang, LY | 1 |
| Shu, HH | 1 |
| Jiang, N | 1 |
| Xie, Y | 1 |
| Duan, Q | 1 |
1 other study available for midazolam and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Down-Regulation; E1A-Associated p300 Protein; Head and | 2014 |